• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自海绵属海洋海绵的半日花烷倍半萜及其法尼醇X受体拮抗活性。

Scalarane sesterterpenes from a marine sponge of the genus Spongia and their FXR antagonistic activity.

作者信息

Nam Sang-Jip, Ko Hyunsil, Ju Moon Kyeong, Hwang Hoosang, Chin Jungwook, Ham Jungyeob, Lee Byoungchan, Lee Jaehwan, Won Dong Hwan, Choi Hyukjae, Ko Jaeyoung, Shin Kyoungjin, Oh Taekyung, Kim Seokho, Rho Jung-Rae, Kang Heonjoong

机构信息

Center for Marine Natural Products and Drug Discovery, School of Earth and Environmental Sciences, Seoul National University, NS-80, Seoul, 151-747, Korea.

出版信息

J Nat Prod. 2007 Nov;70(11):1691-5. doi: 10.1021/np070024k. Epub 2007 Nov 8.

DOI:10.1021/np070024k
PMID:17988093
Abstract

Three new scalarane-based sesterterpenes, 1- 3, were isolated from a marine sponge of the genus Spongia, and their chemical structures were elucidated by analysis of HRMS and 2-D NMR spectra. The isolated compounds 1 and 3 showed inhibition against the farnesoid X-activated receptor (FXR) with IC50 values of 2.4 and 24 microM, respectively. In particular, compound 3 directly inhibited the interaction between FXR and a coactivator peptide (SRC-1) as determined by surface plasmon resonance (SPR) spectroscopy.

摘要

从海绵属的一种海洋海绵中分离出三种新的基于半日花烷的倍半萜烯(1 - 3),并通过高分辨质谱(HRMS)和二维核磁共振(2-D NMR)光谱分析阐明了它们的化学结构。分离出的化合物1和3对法尼醇X激活受体(FXR)具有抑制作用,IC50值分别为2.4和24微摩尔。特别地,通过表面等离子体共振(SPR)光谱测定,化合物3直接抑制FXR与共激活肽(SRC-1)之间的相互作用。

相似文献

1
Scalarane sesterterpenes from a marine sponge of the genus Spongia and their FXR antagonistic activity.来自海绵属海洋海绵的半日花烷倍半萜及其法尼醇X受体拮抗活性。
J Nat Prod. 2007 Nov;70(11):1691-5. doi: 10.1021/np070024k. Epub 2007 Nov 8.
2
Farnesoid X-activated receptor antagonists from a marine sponge Spongia sp.来自海洋海绵Spongia sp.的法尼酯X激活受体拮抗剂
Bioorg Med Chem Lett. 2006 Oct 15;16(20):5398-402. doi: 10.1016/j.bmcl.2006.07.079. Epub 2006 Aug 14.
3
Scalalactams A⁻D, Scalarane Sesterterpenes with a γ-Lactam Moiety from a Korean Spongia Sp. Marine Sponge.沙蟾内酯 A⁻D,来源于一种韩国海绵的海生海绵Scalarane 倍半萜,具有γ-内酰胺部分。
Molecules. 2018 Dec 3;23(12):3187. doi: 10.3390/molecules23123187.
4
Scalarane-based metabolites isolated from the antimitotic extract of the marine sponge Hyrtios erectus.从海洋海绵直立扁枝螅的抗有丝分裂提取物中分离得到的基于半日花烷的代谢产物。
Nat Prod Res. 2008;22(15):1304-9. doi: 10.1080/14786410701824023.
5
Scalarane-based sesterterpenoid RCE-protease inhibitors isolated from the Indonesian marine sponge Carteriospongia foliascens.从印度尼西亚海洋海绵卡特海绵(Carteriospongia foliascens)中分离出的基于半日花烷的倍半萜RCE蛋白酶抑制剂。
J Nat Prod. 2009 Jun;72(6):1106-9. doi: 10.1021/np900042r.
6
Acanthosulfate, a sulfated hydroxyhydroquinone sesterterpenoid from the sponge Acanthodendrilla sp.棘硫酸盐,一种从海绵棘枝海绵属中提取的硫酸化羟基对苯二酚倍半萜类化合物。
J Nat Prod. 2008 Feb;71(2):269-71. doi: 10.1021/np070443h. Epub 2008 Feb 8.
7
Three new cytotoxic sesterterpenes from a marine sponge Spongia sp.从海洋海绵Spongia sp.中分离得到的三种新型细胞毒性倍半萜
J Nat Prod. 2003 Mar;66(3):438-40. doi: 10.1021/np020497l.
8
Cytotoxic scalarane sesterterpenes from a Korean marine sponge Psammocinia sp.一种来自韩国海洋海绵 Psammocinia sp. 的细胞毒性规则甾烷倍半萜
Bioorg Med Chem Lett. 2013 Apr 15;23(8):2336-9. doi: 10.1016/j.bmcl.2013.02.061. Epub 2013 Feb 24.
9
Scalarane sesterterpenes from the sponge Smenospongia sp.来自海绵 Smenospongia sp. 的倍半萜类甾烷
J Nat Prod. 2008 Nov;71(11):1866-71. doi: 10.1021/np8003694. Epub 2008 Oct 30.
10
Cytotoxic scalarane-type sesterterpenes from the Saudi Red Sea sponge Hyrtios erectus.来自沙特红海海绵直立扁海绵的细胞毒性梯形烷型倍半萜烯。
J Asian Nat Prod Res. 2016 Jun;18(6):611-7. doi: 10.1080/10286020.2015.1115019. Epub 2015 Dec 2.

引用本文的文献

1
Farnesoid X receptor regulators from natural products and their biological function.天然产物来源的法尼醇 X 受体调节剂及其生物学功能。
J Tradit Chin Med. 2023 Jun;43(3):618-626. doi: 10.19852/j.cnki.jtcm.20230404.002.
2
Isolation of Scalimides A-L: -Alanine-Bearing Scalarane Analogs from the Marine Sponge sp.Scalimides A-L 的分离:海洋海绵 sp. 中的含 -丙氨酸的Scalarane 类似物
Mar Drugs. 2022 Nov 18;20(11):726. doi: 10.3390/md20110726.
3
The Chemically Highly Diversified Metabolites from the Red Sea Marine Sponge sp.
来自红海海洋海绵 sp. 的化学高度多样化代谢产物
Mar Drugs. 2022 Mar 30;20(4):241. doi: 10.3390/md20040241.
4
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.靶向肝脏X受体或法尼醇X受体的天然产物
Front Pharmacol. 2022 Jan 5;12:772435. doi: 10.3389/fphar.2021.772435. eCollection 2021.
5
An Anti-Inflammatory 2,4-Cyclized-3,4-Secospongian Diterpenoid and Furanoterpene-Related Metabolites of a Marine Sponge sp. from the Red Sea.一种源自红海海绵 sp. 的具有抗炎作用的 2,4-环化-3,4-三亚基二萜和呋喃萜相关代谢物。
Mar Drugs. 2021 Jan 16;19(1):38. doi: 10.3390/md19010038.
6
Scalalactams A⁻D, Scalarane Sesterterpenes with a γ-Lactam Moiety from a Korean Spongia Sp. Marine Sponge.沙蟾内酯 A⁻D,来源于一种韩国海绵的海生海绵Scalarane 倍半萜,具有γ-内酰胺部分。
Molecules. 2018 Dec 3;23(12):3187. doi: 10.3390/molecules23123187.
7
Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening.通过虚拟筛选发现天然产物作为新型强效法尼醇X受体拮抗剂
Front Chem. 2018 Apr 30;6:140. doi: 10.3389/fchem.2018.00140. eCollection 2018.
8
The Role of Spongia sp. in the Discovery of Marine Lead Compounds.海绵属物种在海洋铅化合物发现中的作用。
Mar Drugs. 2016 Jul 23;14(8):139. doi: 10.3390/md14080139.
9
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.基于药效团的 FXR 激动剂发现。第二部分:灵芝中具有生物活性的三萜的鉴定。
Bioorg Med Chem. 2011 Nov 15;19(22):6779-91. doi: 10.1016/j.bmc.2011.09.039. Epub 2011 Sep 29.
10
Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action.2007-2008 年海洋药物学:具有抗菌、抗凝血、抗真菌、抗炎、抗疟原虫、抗原生动物、抗结核和抗病毒活性的海洋化合物;影响免疫和神经系统以及其他各种作用机制。
Comp Biochem Physiol C Toxicol Pharmacol. 2011 Mar;153(2):191-222. doi: 10.1016/j.cbpc.2010.08.008. Epub 2010 Sep 15.